Key result
Pretreatment with Jatropha mollissima extract at /kg prevented the effects of isoproterenol-induced myocardial infarction and preserved biochemical parameters.
Why the study?
The study aimed to explore the cardioprotective effects of various doses of Jatropha mollissima extract against isoproterenol-induced myocardial infarction in rats.
Does Jatropha mollissima leaf extract prevent isoproterenol-induced myocardial infarction in a rat model?
Does Jatropha mollissima leaf extract prevent isoproterenol-induced myocardial infarction in a rat model?
Jatropha mollissima leaf extract demonstrates dose-dependent cardioprotective and antioxidant effects against isoproterenol-induced myocardial infarction in a rat model.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; leaves open translation of Jatropha mollissima cardioprotection to human myocardial infarction.
We aim to explore various effects of doses of Jatropha mollissima against isoproterenol-induced myocardial infarction in the rat. Rats were divided into 6 groups (10 rats in each). Group-1 was normal to control, and Group-2 was considered intoxicated isoproterenol (ISP) (100 mg/kg, s. c.) Group-3 was treated with standard drug carvedilol, while Group-4, 5, and 6 were treatment groups and treated with J. mollissima extract at the doses of 400, 600, and 800 mg/kg, respectively. Preliminary phytochemistry, histopathological variation in the myocardium, antioxidant potential, and cardiac biomarkers (serum glutamic oxaloacetic transaminase, triglyceride, 2,4,6-trinitrotoluene, serum glutamic pyruvic transaminase, lactate dehydrogenase, and creatine kinase muscle–brain fraction), cardiac rate, electrocardiographing, and pressurization rate index were estimated. This study indicates that the extract proved to have cardioprotective potential and significantly reduced the cardiac biomarkers in a dose-dependent fashion because of flavonoid contents and antioxidant property. The histopathological analysis shows marked improvement in J. mollissima groups handled in comparison with ISP. The present evaluation suggests that J. mollissima has exceptional cardioprotective potential contrary to toxicity caused by isoproterenol. We recommend further studies at the molecular level to frame the exact mechanism of action.
No takes yet. Share an insight, caveat, or question.
Iqbal et al. (2021) studied Isoproterenol-induced myocardial infarction (n=60). Jatropha mollissima hydroalcoholic leaf extract vs. Isoproterenol alone (negative control) and carvedilol (standard drug) was evaluated on Cardiac biomarkers and antioxidant parameters (p=<0.001). Pretreatment with Jatropha mollissima extract at /kg prevented the effects of isoproterenol-induced myocardial infarction and preserved biochemical parameters.
Synapse has enriched 10 related papers. Consider them for comparative context: